GET THE APP

Analysis of the Binding Sites for Protoporphyrin IX on Human Serum Albumin using Molecular Docking
..

Journal of Surgery

ISSN: [Jurnalul de chirurgie]
ISSN: 1584-9341

Open Access

Brief Report - (2024) Volume 20, Issue 5

Analysis of the Binding Sites for Protoporphyrin IX on Human Serum Albumin using Molecular Docking

Alejandro Gonzalez*
*Correspondence: Alejandro Gonzalez, Department of Vascular Surgery, University of Groningen, University Medical Center Groningen, 9700 VB Groningen, The Netherlands, Netherlands, Email:
Department of Vascular Surgery, University of Groningen, University Medical Center Groningen, 9700 VB Groningen, The Netherlands, Netherlands

Received: 02-Sep-2024, Manuscript No. jos-24-154442; Editor assigned: 04-Sep-2024, Pre QC No. P-154442; Reviewed: 18-Sep-2024, QC No. Q-154442; Revised: 23-Sep-2024, Manuscript No. R-154442; Published: 30-Sep-2024 , DOI: 10.37421/1584-9341.2024.20.166
Citation: Gonzalez, Alejandro. “Analysis of the Binding Sites for Protoporphyrin IX on Human Serum Albumin using Molecular Docking.” J Surg 20 (2024): 166.
Copyright: © 2024 Gonzalez A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Introduction

The study of protein-ligand interactions is fundamental to understanding many biological processes, from cellular signaling to metabolic pathways. In this context, Human Serum Albumin (HSA) is a key protein in the blood plasma that plays a crucial role in transporting a wide variety of endogenous and exogenous compounds, including hormones, fatty acids and pharmaceuticals. HSA, with its versatile binding properties, is a subject of extensive research due to its ability to bind a wide range of ligands, which can alter its conformation and thus its function in physiological and pathological conditions. Protoporphyrin IX (PpIX) is a naturally occurring porphyrin derivative that plays an essential role in the biosynthesis of heme, the prosthetic group of hemoglobin, myoglobin and cytochromes. As a component of heme, PpIX is involved in oxygen transport and cellular respiration. Given its structural characteristics, including a tetrapyrrolic ring structure with metal-binding properties, PpIX can also form complexes with various proteins, including HSA. The interactions between HSA and PpIX are of particular interest in the context of heme metabolism, the transport of porphyrins and the potential toxicological effects of porphyrin overload [1].

The interaction between PpIX and HSA is not just of academic interest, but also of clinical significance. The binding of PpIX to HSA could impact its bioavailability, distribution and elimination, influencing its physiological roles and potential toxicity. For instance, the binding of PpIX to HSA may serve as a protective mechanism against the accumulation of excess porphyrins in tissues, thereby mitigating their potential to cause oxidative stress and cellular damage. Furthermore, understanding the molecular details of the binding interactions between PpIX and HSA could facilitate the design of novel therapeutic strategies for diseases associated with porphyrin metabolism, such as porphyria. Molecular docking is a computational technique that has become an indispensable tool for studying protein-ligand interactions. By predicting the preferred binding orientations of ligands within a protein's binding site, molecular docking provides valuable insights into the molecular mechanisms underlying these interactions. In this study, we aim to analyze the binding sites of protoporphyrin IX (PpIX) on human serum albumin using molecular docking simulations. The goal is to identify the primary binding sites for PpIX on HSA, understand the nature of the binding interactions and explore the potential implications of these interactions in terms of PpIX transport and pharmacokinetics [2].

Description

Human serum albumin is a 66.5 kDa glycoprotein composed of a single polypeptide chain consisting of 585 amino acid residues. It is the most abundant protein in human plasma, accounting for approximately 50-60% of the total protein content. HSA has a highly flexible structure that allows it to bind a wide variety of ligands with high affinity and specificity. The protein is divided into three distinct domains, known as domains I, II and III. Each of these domains is further subdivided into subdomains that form a series of hydrophobic and hydrophilic pockets capable of binding ligands. HSA's ability to bind multiple ligands is crucial for its role in transporting various endogenous and exogenous molecules. The ligand-binding sites on HSA are distributed across its three domains, with the most prominent binding sites located in subdomains IIA, IIB and IIIA. The binding of ligands to HSA is influenced by the specific chemical and structural properties of the ligands, as well as the conformational flexibility of HSA. Understanding these binding interactions is key to elucidating the protein’s physiological and pharmacological roles [3].

Protoporphyrin IX is a tetrapyrrole molecule that serves as an immediate precursor to heme. It is synthesized in the mitochondria of cells, primarily in the liver and bone marrow, through a series of enzymatic reactions. PpIX contains a central iron atom that coordinates with four nitrogen atoms of the porphyrin ring, a feature that allows it to bind metal ions and participate in redox reactions. PpIX itself is a precursor in the biosynthesis of heme, which is essential for oxygen transport in the bloodstream and cellular respiration in mitochondria.

Apart from its role in heme synthesis, PpIX has been studied for its potential in photodynamic therapy (PDT), particularly in cancer treatment. PpIX can accumulate in certain tumor cells and, when exposed to light, can generate reactive oxygen species that damage the tumor cells. In addition, PpIX and its derivatives have been implicated in various metabolic disorders, including porphyria, a group of diseases caused by defects in the enzymes responsible for porphyrin synthesis. Elevated levels of PpIX can lead to photosensitivity, liver dysfunction and other health complications. Given PpIX’s role in the body, understanding how it interacts with plasma proteins such as HSA is important for comprehending its pharmacokinetics and therapeutic applications. The binding of PpIX to HSA can affect its distribution, clearance and tissue penetration, which in turn impacts its therapeutic efficacy and toxicity [4].

Molecular docking is a computational technique that predicts the preferred binding modes of a ligand (e.g., a small molecule, peptide, or other bioactive compound) to a target protein. It allows researchers to simulate the interaction between a ligand and its receptor, providing insights into the binding affinity, the most likely binding site and the orientation of the ligand within the receptor. Docking algorithms typically rely on scoring functions that evaluate the strength and stability of the interaction between the ligand and the protein [5] .

Conclusion

The interaction between Proto porphyrin IX (PpIX) and Human Serum Albumin (HSA) plays an essential role in the transport and distribution of PpIX in the body. By analyzing the binding sites for PpIX on HSA using molecular docking techniques, we can gain valuable insights into the molecular mechanisms underlying this interaction. Understanding how PpIX binds to HSA can inform our knowledge of its pharmacokinetics, its role in heme metabolism and its potential therapeutic applications, particularly in the context of photodynamic therapy for cancer and the management of porphyrinrelated disorders. The results of this study will contribute to a more detailed understanding of the interaction between PpIX and HSA, which could have important implications for drug delivery, therapeutic interventions and the design of new porphyrin-based drugs. Furthermore, this study exemplifies the power of molecular docking in exploring protein-ligand interactions and its potential to inform the design of novel therapeutics.

Acknowledgment

None.

Conflict of Interest

None.

References

  1. Lee, Scott S., Douglas J. Kiserow and Linda B. McGown. "Enzyme solubilization in a reversed micellar microreactor with a bile salt cosurfactant." J Colloid Interface Sci 193 (1997): 32-40.
  2. Google Scholar, Crossref, Indexed at

  3. Sudlow, G. D. J. B., D. J. Birkett and D. N. Wade. "The characterization of two specific drug binding sites on human serum albumin." Mol Pharmacol 11 (1975): 824-832.
  4. Google Scholar, Indexed at

  5. Carter, Daniel C. and Joseph X. Ho. "Structure of serum albumin." Adv Protein Chem 45 (1994): 153-203.
  6. Google Scholar, Indexed at

  7. Storm, Carlyle B., Yohannes Teklu and Edward A. Sokoloski. "N‐H TAUTOMERISM IN PORPHYRINS AND CHLORINS." Ann N Y Acad Sci 206 (1973): 631-640.
  8. Google Scholar, Crossref, Indexed at

  9. Sugio, Shigetoshi, Akiko Kashima, Shinichi Mochizuki and Mariko Noda, et al "Crystal structure of human serum albumin at 2.5 Å resolution." Protein Eng 12 (1999): 439-446.
  10. Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 288

Journal of Surgery received 288 citations as per Google Scholar report

Journal of Surgery peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward